Author

Raphael Micheroli

Department of Rheumatology, University Hospital of Zurich, University of Zurich, Switzerland.;Primary ORCID profile (0000-0002-8918-7304 · 7 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Raphael MicheroliiD7 papers · University of Zurich

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Axel FinckhiD· 1 shared Burkhard Moeller· 1 shared Cem Gabay· 1 shared Delphine S Courvoisier· 1 shared Denis Mongin· 1 shared Matthias JarlborgiD· 1 shared Michael J Nissen· 1 shared Nicolas Vuilleumier· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Axel FinckhORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality

Seimia Chebbi, Denis Mongin, Delphine S Courvoisier, Michael J Nissen, Burkhard Moeller, Raphael Micheroli, Cem Gabay, Nicolas Vuilleumier, Axel Finckh, Matthias Jarlborg

This study evaluates serum calprotectin as a biomarker for disease activity, severity, cardiovascular risk, and mortality in inflammatory rheumatic diseases, finding it to be a better predictor than CRP in certain contexts.

bioRxiv · Nov 3, 2026 · PreprintImmunology